BioTheryX, Immuta and Pitch are among the companies that have raised fresh capital from corporates such as Intel Capital, Slack Fund, Citi Ventures and Dell Technologies Capital.
Funding US-based cancer treatment developer BioTheryX has raised $92m in a series E round backed by Alexandria Venture Investment, the investment arm of life sciences real estate trust Alexandria Real Estate Equities. The round was led by Farallon Capital Management, with participation from additional investors Avidity Partners, Deep Track Capital, Irving Investors, Janus Henderson Investors,…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
